| Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis R Kahn, P Alperin, D Eddy, K Borch-Johnsen, J Buse, J Feigelman, ... The Lancet 375 (9723), 1365-1374, 2010 | 345 | 2010 |
| Immunoaffinity isolation of urinary 8-hydroxy-2′-deoxygunosine and 8-hydroxyguanine and quantitation of 8-hydroxy-2′ deoxyguanosine in DNA by polyclonal antibodies P Degan, MK Shigenaga, EM Park, PE Alperin, BN Ames Carcinogenesis 12 (5), 865-871, 1991 | 178 | 1991 |
| Modeling effects of SGLT‐2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes J Dziuba, P Alperin, J Racketa, U Iloeje, D Goswami, E Hardy, I Perlstein, ... Diabetes, Obesity and Metabolism 16 (7), 628-635, 2014 | 129 | 2014 |
| Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine. JT MacGregor, R Schlegel, CM Wehr, P Alperin, BN Ames Proceedings of the National Academy of Sciences 87 (24), 9962-9965, 1990 | 110 | 1990 |
| Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer T Dinh, U Ladabaum, P Alperin, C Caldwell, R Smith, TR Levin Clinical Gastroenterology and Hepatology 11 (9), 1158-1166, 2013 | 53 | 2013 |
| A standardized vascular disease health check in Europe: a cost-effectiveness analysis CA Schuetz, P Alperin, S Guda, A van Herick, B Cariou, D Eddy, ... PloS one 8 (7), e66454, 2013 | 52 | 2013 |
| Does a fixed physician reminder system improve the care of patients with coronary artery disease? A randomized controlled trial CD Frances, P Alperin, JS Adler, D Grady Western Journal of Medicine 175 (3), 165, 2001 | 35 | 2001 |
| Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis JA Gaebler, G Soto-Campos, P Alperin, M Cohen, A Blickensderfer, ... Vascular Health and Risk Management, 255-264, 2012 | 32 | 2012 |
| Cost‐effectiveness of chemoprevention of breast cancer using tamoxifen in a postmenopausal US population J Noah‐Vanhoucke, LE Green, TA Dinh, P Alperin, RA Smith Cancer 117 (15), 3322-3331, 2011 | 31 | 2011 |
| Modeling the impact of increased adherence to asthma therapy A Schlender, PE Alperin, HL Grossman, ER Sutherland PLoS One 7 (12), e51139, 2012 | 27 | 2012 |
| Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemia S Samuel, B Peskin, B Arondekar, P Alperin, S Johnson, I Blumenfeld, ... The American journal of cardiology 108 (5), 691-697, 2011 | 27 | 2011 |
| Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations TA Dinh, P Alperin, LC Walter, R Smith Journal of general internal medicine 27, 730-738, 2012 | 26 | 2012 |
| Simulating the impact of improved cardiovascular risk interventions on clinical and economic outcomes in Russia K Shum, P Alperin, S Shalnova, S Boytsov, A Kontsevaya, A Vigdorchik, ... PLoS One 9 (8), e103280, 2014 | 24 | 2014 |
| Comparing the effectiveness of rosuvastatin and atorvastatin in preventing cardiovascular outcomes: estimates using the Archimedes model CA Schuetz, A van Herick, P Alperin, B Peskin, J Hsia, S Gandhi Journal of Medical Economics 15 (6), 1118-1129, 2012 | 22 | 2012 |
| The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model A van Herick, CA Schuetz, P Alperin, MF Bullano, S Balu, S Gandhi ClinicoEconomics and Outcomes Research, 337-347, 2012 | 16 | 2012 |
| Modeling the effects of omalizumab over 5 years among patients with moderate-to-severe persistent allergic asthma HL Grossman, A Schlender, P Alperin, EL Stanley, J Zhang Current medical research and opinion 26 (12), 2779-2793, 2010 | 10 | 2010 |
| A behavior-driven mathematical model of medication compliance T Dinh, P Alperin The 33rd Annual Meeting of the Society for Medical Decision Making. Society …, 2011 | 4 | 2011 |
| Understanding the effect of glycemic control on macrovascular outcomes in patients with diabetes using the Archimedes Model P Alperin, G Soto-Campos, B Peskin, A Shcheprov, T van Nguyen, ... Diabetes 59, 2010 | 4 | 2010 |
| Cost-effectiveness of adding information about common risk alleles to current decision models for breast cancer chemoprevention. T Dinh, L Green, P Alperin, D Hinds, B Walser Journal of Clinical Oncology 28 (15_suppl), 6042-6042, 2010 | 2 | 2010 |
| Devices, systems and methods for rendering, updating and communicating relationship information P Harding, A Guetz, P Alperin US Patent App. 14/340,441, 2016 | 1 | 2016 |
